National Comprehensive Cancer Network



About NCCN

Cervical/Uterine Cancers Panel - Disclosures as of 5/27/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Nadeem R. Abu-Rustum, MD

None

None

None

None

None

Sachin M. Apte, MD, MS, MBA

None

None

None

None

None

Robert E. Bristow, MD

John`s Hopkins University

Genzyme Corporation;
Oncotech

None

Genzyme Inc.

None

Susana M. Campos, MD, MPH, MS

None

None

None

None

None

John Chan, MD

None

Ortho Biotech Products, L.P.

None

None

None

Kathleen R. Cho, MD

None

None

None

None

None

Larry Copeland, MD

None

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

None

Marta Ann Crispens, MD

None

None

None

None

None

Nefertiti DuPont, MD, MPH

None

None

None

None

None

Patricia J. Eifel, MD

None

None

None

None

None

David K. Gaffney, MD, PhD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Benjamin E. Greer, MD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Miranda Hughes, PhD

None

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

Warner K. Huh, MD

None

GlaxoSmithKline;
Intuitive Surgical, Inc.;
Merck & Co., Inc.;
Helix BioPharm

None

None

None

Daniel S. Kapp, MD, PhD

None

None

None

None

None

Wui-Jin Koh, MD

None

None

None

None

None

John R. Lurain, MD

None

None

None

None

None

Lainie Martin, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nicole McMillian, MS

None

None

None

None

None

Mark A. Morgan, MD, FACOG, FACS

None

None

None

None

None

Robert J. Morgan, MD, FACP

NIH-CTEP

None

None

Abbott Laboratories

None

David Mutch, MD

None

None

None

None

None

Steven W. Remmenga, MD

None

None

None

None

None

R. Kevin Reynolds, MD

None

None

None

None

None

Angeles A. Secord, MD

Bristol-Myers Squibb Company

Abraxis Oncology;
Eli Lilly and Company;
Eli Lilly and Company;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
sanofi-aventis U.S.

None

None

None

William Small, MD

None

DOR BioPharma, Inc.

None

None

None

Nelson Teng, MD, PhD

None

None

None

None

None